Squibb
Executive Summary
Licenses BVaraU antiviral agent from Yamsa Shoyu of Japan. BVaraU is being investigated for treating shingles and cold sores caused by the herpes zoster and herpes simplex virus. Squibb filed for an IND in February; clinical trials are expected to begin in the U.S. and Europe in late 1989.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.